Our unique Real World Evidence process works by gathering data from real product users, using academically validated questions through our bespoke digital platform. Users are recruited through various sources, across the brand's and our own existing digital ecosystems and in-person patient information points.
This innovative blend of modern and traditional recruitment methods allows us to access a wider consumer base to seek out dynamic and representative cohorts. Wherever patients can be found, we will reach them.
Digital Real World Evidence can be applied to many different scenarios within consumer healthcare brands and services. Particularly, over-the-counter medicines, medical devices, food supplements and any situation where a large amount of high-grade clinical data is needed quickly, such as in a wider academic study on the effects of illness or injury. We're always looking to innovate and there is no limit to the range of projects Real World Evidence can be applied to.
However, this is not the limit - wherever patients can be found, we will seek them out.
The data for these studies comes from existing users of a product, who voluntarily answer questions on a bespoke platform. As required by the medical protocol for our studies, we are upfront with users as to why we are running the study and we explain to them how this data is used. All data collected is anonymous and cannot be tracked back to an individual. We do not “mine” data through user's social profiles, collect personal information or rack up data collected through user online tracking.
Orbital Research's Real World Evidence methodology offers a cost-saving alternative to clinical trials (RCTs) as a way of gathering high-grade medical insight data - typically at less than 10% of the costs of these trials.
Aside from being a far cheaper cost than a clinical trial, this method also has several other significant advantages:
From initial discussions, through to project completion can take between 6-12 months, but this is dependent upon many factors established early on in the project process.
No. Unlike a clinical trial (RCT), with our digital RWE methodology the results do not need to be published in most jurisdictions if you don’t wish them to be.
Absolutely. Our studies are massively insightful for obtaining high level clinical data for any reason that you may need it. It can be used, for example, as supplementary data to a regulatory request or to submit to a notified body to support MDR compliance. Whether your requirements are regulatory or for marketing purposes, Real World Evidence can help to gather the data you need on demand.
In an ever-competitive market, brand managers need every edge. New product claims can not only revitalise a brand and help it to remain current in the consumers eyes, but additionally provide a healthy, competitive edge that can be shared across all marketing materials, be it above or below the line.
Nothing can ever be guaranteed, however our experience and knowledge will help us define likely outcomes at an early stage of the study. So far, we have a 100% success rate in achieving the goals of our clients.
We can help to find product users in all areas of the digital and in-person landscapes. Wherever your consumers are, we can help to reach them.
“Orbital Research are recognised as the number one world-leading experts in Digital Real World Evidence”
- AESGP Conference